Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

CVR Medical Corp V.CVM.H

Alternate Symbol(s):  CRRVF

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool, which complements other stroke screening technology such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA) and computed tomography angiography (CTA). The CSS is non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers.


TSXV:CVM.H - Post by User

Bullboard Posts
Comment by ICT1111on Mar 22, 2020 7:49pm
117 Views
Post# 30835902

RE:RE:CVR MEDICAL CORP

RE:RE:CVR MEDICAL CORPKind of you to say ....... Bakema offered me a directorship in exchange for a further investment in September last year ...... it was clear that he was after money not expertise; he said he was talking to and looking to appoint 'a number of new directors' ....... I realised that he meant 'I will take money from anyone' and 'Money is more important than expertise' ....... Kanter, Hellman, Lubow and D'Orta were/are well capable of unwinding the current situation, guiding us towards FDA approval/TSX acceptance whilst building the leadership team that are going to commercialise this. Ultimately we, as shareholders, should be asked to vote on this ....... lets see what happens.
Bullboard Posts